Skip to content

Clinical trials

Completed Neoplasm Metastasis trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Completed Country / region: India Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20065
20073
20081
20094
20101
20111
20122
20131
20141
20171
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Eli Lilly and Company2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Pfizer2
Sanofi2
BioMarck Pharmaceuticals, Ltd.1
ImmunityBio, Inc.1
Imugene Limited1
International Breast Cancer Research Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis23
Breast Neoplasms7
Colorectal Neoplasms4
Adenocarcinoma3
Carcinoma, Medullary2
Carcinoma, Renal Cell2
Colonic Neoplasms2
Neoplasms2
Rectal Neoplasms2
Anemia1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.